Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2024-2031

Report ID: 954878 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Effector Binding
        1.2.3 ELISA
        1.2.4 Kinetic Binding Assays
        1.2.5 ADCC & CDC Cell-Based Assays
    1.3 Market by Application
        1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 PK assay
        1.3.3 Tiered Immunogenicity testing
        1.3.4 NAb assays
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Biosimilar Testing and Development Services Market Perspective (2016-2027)
    2.2 Biosimilar Testing and Development Services Growth Trends by Regions
        2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2016-2021)
        2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2022-2027)
    2.3 Biosimilar Testing and Development Services Industry Dynamic
        2.3.1 Biosimilar Testing and Development Services Market Trends
        2.3.2 Biosimilar Testing and Development Services Market Drivers
        2.3.3 Biosimilar Testing and Development Services Market Challenges
        2.3.4 Biosimilar Testing and Development Services Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
        3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2016-2021)
        3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2016-2021)
    3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
    3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
        3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2020
    3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
    3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
    3.7 Date of Enter into Biosimilar Testing and Development Services Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Testing and Development Services Breakdown Data by Type
    4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2016-2021)
    4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2022-2027)

5 Biosimilar Testing and Development Services Breakdown Data by Application
    5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2016-2021)
    5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Biosimilar Testing and Development Services Market Size (2016-2027)
    6.2 North America Biosimilar Testing and Development Services Market Size by Type
        6.2.1 North America Biosimilar Testing and Development Services Market Size by Type (2016-2021)
        6.2.2 North America Biosimilar Testing and Development Services Market Size by Type (2022-2027)
        6.2.3 North America Biosimilar Testing and Development Services Market Size by Type (2016-2027)
    6.3 North America Biosimilar Testing and Development Services Market Size by Application
        6.3.1 North America Biosimilar Testing and Development Services Market Size by Application (2016-2021)
        6.3.2 North America Biosimilar Testing and Development Services Market Size by Application (2022-2027)
        6.3.3 North America Biosimilar Testing and Development Services Market Size by Application (2016-2027)
    6.4 North America Biosimilar Testing and Development Services Market Size by Country
        6.4.1 North America Biosimilar Testing and Development Services Market Size by Country (2016-2021)
        6.4.2 North America Biosimilar Testing and Development Services Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Biosimilar Testing and Development Services Market Size (2016-2027)
    7.2 Europe Biosimilar Testing and Development Services Market Size by Type
        7.2.1 Europe Biosimilar Testing and Development Services Market Size by Type (2016-2021)
        7.2.2 Europe Biosimilar Testing and Development Services Market Size by Type (2022-2027)
        7.2.3 Europe Biosimilar Testing and Development Services Market Size by Type (2016-2027)
    7.3 Europe Biosimilar Testing and Development Services Market Size by Application
        7.3.1 Europe Biosimilar Testing and Development Services Market Size by Application (2016-2021)
        7.3.2 Europe Biosimilar Testing and Development Services Market Size by Application (2022-2027)
        7.3.3 Europe Biosimilar Testing and Development Services Market Size by Application (2016-2027)
    7.4 Europe Biosimilar Testing and Development Services Market Size by Country
        7.4.1 Europe Biosimilar Testing and Development Services Market Size by Country (2016-2021)
        7.4.2 Europe Biosimilar Testing and Development Services Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2016-2027)
    8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type
        8.2.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2027)
    8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application
        8.3.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2027)
    8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region
        8.4.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Biosimilar Testing and Development Services Market Size (2016-2027)
    9.2 Latin America Biosimilar Testing and Development Services Market Size by Type
        9.2.1 Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2021)
        9.2.2 Latin America Biosimilar Testing and Development Services Market Size by Type (2022-2027)
        9.2.3 Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2027)
    9.3 Latin America Biosimilar Testing and Development Services Market Size by Application
        9.3.1 Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2021)
        9.3.2 Latin America Biosimilar Testing and Development Services Market Size by Application (2022-2027)
        9.3.3 Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2027)
    9.4 Latin America Biosimilar Testing and Development Services Market Size by Country
        9.4.1 Latin America Biosimilar Testing and Development Services Market Size by Country (2016-2021)
        9.4.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2016-2027)
    10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type
        10.2.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2027)
    10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application
        10.3.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2027)
    10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country
        10.4.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Eurofins Scientific
        11.1.1 Eurofins Scientific Company Details
        11.1.2 Eurofins Scientific Business Overview
        11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
        11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.1.5 Eurofins Scientific Recent Development
    11.2 SGS
        11.2.1 SGS Company Details
        11.2.2 SGS Business Overview
        11.2.3 SGS Biosimilar Testing and Development Services Introduction
        11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.2.5 SGS Recent Development
    11.3 Charles River Laboratories
        11.3.1 Charles River Laboratories Company Details
        11.3.2 Charles River Laboratories Business Overview
        11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
        11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.3.5 Charles River Laboratories Recent Development
    11.4 Pharmaceutical Product Development
        11.4.1 Pharmaceutical Product Development Company Details
        11.4.2 Pharmaceutical Product Development Business Overview
        11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
        11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.4.5 Pharmaceutical Product Development Recent Development
    11.5 Exova
        11.5.1 Exova Company Details
        11.5.2 Exova Business Overview
        11.5.3 Exova Biosimilar Testing and Development Services Introduction
        11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.5.5 Exova Recent Development
    11.6 Source BioScience
        11.6.1 Source BioScience Company Details
        11.6.2 Source BioScience Business Overview
        11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
        11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.6.5 Source BioScience Recent Development
    11.7 Intertek Group
        11.7.1 Intertek Group Company Details
        11.7.2 Intertek Group Business Overview
        11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
        11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.7.5 Intertek Group Recent Development
    11.8 Medistri
        11.8.1 Medistri Company Details
        11.8.2 Medistri Business Overview
        11.8.3 Medistri Biosimilar Testing and Development Services Introduction
        11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.8.5 Medistri Recent Development
    11.9 Pace Analytical Services
        11.9.1 Pace Analytical Services Company Details
        11.9.2 Pace Analytical Services Business Overview
        11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
        11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.9.5 Pace Analytical Services Recent Development
    11.10 Sigma-Aldrich
        11.10.1 Sigma-Aldrich Company Details
        11.10.2 Sigma-Aldrich Business Overview
        11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
        11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2016-2021)
        11.10.5 Sigma-Aldrich Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Effector Binding
    Table 3. Key Players of ELISA
    Table 4. Key Players of Kinetic Binding Assays
    Table 5. Key Players of ADCC & CDC Cell-Based Assays
    Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Biosimilar Testing and Development Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Biosimilar Testing and Development Services Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Biosimilar Testing and Development Services Market Share by Regions (2016-2021)
    Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Biosimilar Testing and Development Services Market Share by Regions (2022-2027)
    Table 12. Biosimilar Testing and Development Services Market Trends
    Table 13. Biosimilar Testing and Development Services Market Drivers
    Table 14. Biosimilar Testing and Development Services Market Challenges
    Table 15. Biosimilar Testing and Development Services Market Restraints
    Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2016-2021)
    Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2020)
    Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
    Table 23. Date of Enter into Biosimilar Testing and Development Services Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2016-2021)
    Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Biosimilar Testing and Development Services Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2016-2021)
    Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Eurofins Scientific Company Details
    Table 64. Eurofins Scientific Business Overview
    Table 65. Eurofins Scientific Biosimilar Testing and Development Services Product
    Table 66. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 67. Eurofins Scientific Recent Development
    Table 68. SGS Company Details
    Table 69. SGS Business Overview
    Table 70. SGS Biosimilar Testing and Development Services Product
    Table 71. SGS Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 72. SGS Recent Development
    Table 73. Charles River Laboratories Company Details
    Table 74. Charles River Laboratories Business Overview
    Table 75. Charles River Laboratories Biosimilar Testing and Development Services Product
    Table 76. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 77. Charles River Laboratories Recent Development
    Table 78. Pharmaceutical Product Development Company Details
    Table 79. Pharmaceutical Product Development Business Overview
    Table 80. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
    Table 81. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 82. Pharmaceutical Product Development Recent Development
    Table 83. Exova Company Details
    Table 84. Exova Business Overview
    Table 85. Exova Biosimilar Testing and Development Services Product
    Table 86. Exova Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 87. Exova Recent Development
    Table 88. Source BioScience Company Details
    Table 89. Source BioScience Business Overview
    Table 90. Source BioScience Biosimilar Testing and Development Services Product
    Table 91. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 92. Source BioScience Recent Development
    Table 93. Intertek Group Company Details
    Table 94. Intertek Group Business Overview
    Table 95. Intertek Group Biosimilar Testing and Development Services Product
    Table 96. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 97. Intertek Group Recent Development
    Table 98. Medistri Company Details
    Table 99. Medistri Business Overview
    Table 100. Medistri Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 101. Medistri Recent Development
    Table 102. Pace Analytical Services Company Details
    Table 103. Pace Analytical Services Business Overview
    Table 104. Pace Analytical Services Biosimilar Testing and Development Services Product
    Table 105. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 106. Pace Analytical Services Recent Development
    Table 107. Sigma-Aldrich Company Details
    Table 108. Sigma-Aldrich Business Overview
    Table 109. Sigma-Aldrich Biosimilar Testing and Development Services Product
    Table 110. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2016-2021) & (US$ Million)
    Table 111. Sigma-Aldrich Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2020 VS 2027
    Figure 2. Effector Binding Features
    Figure 3. ELISA Features
    Figure 4. Kinetic Binding Assays Features
    Figure 5. ADCC & CDC Cell-Based Assays Features
    Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2027
    Figure 7. PK assay Case Studies
    Figure 8. Tiered Immunogenicity testing Case Studies
    Figure 9. NAb assays Case Studies
    Figure 10. Biosimilar Testing and Development Services Report Years Considered
    Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Biosimilar Testing and Development Services Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Biosimilar Testing and Development Services Market Share by Regions: 2020 VS 2027
    Figure 14. Global Biosimilar Testing and Development Services Market Share by Regions (2022-2027)
    Figure 15. Global Biosimilar Testing and Development Services Market Share by Players in 2020
    Figure 16. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Testing and Development Services as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2020
    Figure 18. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2016-2021)
    Figure 19. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2022-2027)
    Figure 20. North America Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Biosimilar Testing and Development Services Market Share by Type (2016-2027)
    Figure 22. North America Biosimilar Testing and Development Services Market Share by Application (2016-2027)
    Figure 23. North America Biosimilar Testing and Development Services Market Share by Country (2016-2027)
    Figure 24. United States Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Biosimilar Testing and Development Services Market Share by Type (2016-2027)
    Figure 28. Europe Biosimilar Testing and Development Services Market Share by Application (2016-2027)
    Figure 29. Europe Biosimilar Testing and Development Services Market Share by Country (2016-2027)
    Figure 30. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Biosimilar Testing and Development Services Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Biosimilar Testing and Development Services Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2016-2027)
    Figure 40. China Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Biosimilar Testing and Development Services Market Share by Type (2016-2027)
    Figure 48. Latin America Biosimilar Testing and Development Services Market Share by Application (2016-2027)
    Figure 49. Latin America Biosimilar Testing and Development Services Market Share by Country (2016-2027)
    Figure 50. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Biosimilar Testing and Development Services Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Biosimilar Testing and Development Services Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2016-2027)
    Figure 56. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 60. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 61. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 62. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 63. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 64. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 65. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 66. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 67. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 68. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Frequently Asked Questions
Biosimilar Testing and Development Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Testing and Development Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Testing and Development Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bleeding Disorders

The bleeding disorder is a condition in which there is a problem associated with the normal blood ... Read More

Blockchain in Retail

Blockchain in retail refers to the technology that maintains and manages distributed database con ... Read More